Session 10: Global Perspective on CLL Management - Real World Data and Patient Experiences

Co-Chair(s)

• 

  Anna Schuh, MD, PhD, FRCP, FRCPath

  Director of Molecular Diagnostics (Oxford Molecular Diagnostic Centre), Professor of Molecular Diagnostics (Department of Oncology)
  Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
  Oxford, United Kingdom
• 

  Geoffrey Cook

  The Max Foundation
  Seattle, Washington, United States

Presentations:

• 1:55 PM – 2:00 PM EDT

  Special Announcement from the iwCLL
  

  Speaker: Anna Schuh, MD, PhD, FRCP, FRCPath – Oxford Molecular Diagnostic Centre, Department of Oncology, University of Oxford
• 2:00 PM – 2:10 PM EDT

  The Impact of the War on Management of Patients with CLL in Ukraine: What can the iwCLL do to Mitigate Impact in Short and Longer Term
  

  Speaker: Iryna Kriachok, PhD MD Prof – National Cancer Institute
• 2:10 PM – 2:20 PM EDT

  Managing Patients with CLL from Different Socio-Economic Backgrounds in Argentina
  

  Speaker: Miguel A. Pavlovksy, MD – FUNDALEU, Clinical Research Center Buenos Aires
• 2:20 PM – 2:30 PM EDT

  Update on the iwCLL Capacity Building Pilot Program in Tanzania
  

  Speaker: William Frank Mawalla, MD, MMED – Muhimbili University of Health and Allied Sciences
• 2:30 PM – 2:40 PM EDT

  Challenges of Diagnosis and Management of Patients with CLL in South Korea
  

  Speaker: Ja Min Byun, MD, PhD – Seoul National University College of Medicine
• 2:40 PM – 2:50 PM EDT

  Trial Updates from China
  

  Speaker: Shenmiao Yang, MD – Peking University People's Hospital, Hematology Department, Beijing, China
• 2:50 PM – 3:00 PM EDT

  Global Survey Results from the CLL Advocates Network
  

  Speaker: Brian Koffman, MDCM, FCFP, DABFM, MS Ed – CLL Advocates Network
• 3:00 PM – 3:10 PM EDT

  A high proportion of IGHV4-39, subset#8 and #8B in Chinese patients with chronic lymphocytic leukemia: a retrospective analysis of 3154 Ig VH sequences by cwCLL, Chinese workshop on CLL
  

  Primary Author; Presenting Author: Yi Xia, MD – the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

  Co-Author: Tonglu Qiu, Dr – Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

  Co-Author: Shuhua Yi, Dr – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College

  Co-Author: Chun Qiao, Dr – Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

  Co-Author: Huayuan Zhu, MD – the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

  Co-Author: Yuting Yan, Dr – State Key Laboratory of Experimental Hematology, National Clinical Research Center for Blood Diseases, Blood Diseases Hospital & Institute of Hematology, Chinese Academy of Medical Sciences & Peking Union Medical College

  Co-Author: Li Yao, Dr – Department of Hematology, First Affiliated Hospital of Soochow University, Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases

  Co-Author: Mingqing Zhu, Dr – Department of Hematology, First Affiliated Hospital of Soochow University, Soochow University, Jiangsu Institute of Hematology, National Clinical Research Center for Hematologic Diseases

  Co-Author: Hongling Peng, Dr – Department of Hematology, The Second Xiangya Hospital, Central South University

  Co-Author: Heng Li, MD – Department of Hematology, The Second Xiangya Hospital, Central South University

  Co-Author: Liang Huang, Dr – Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

  Co-Author: Min Xiao, Dr – Department of Hematology, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology

  Co-Author: Jie Jin, Dr – Department of Hematology, The First Affiliated Hospital, Zhejiang University School of Medicine

  Co-Author: Jianqing Mi, Dr – Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

  Co-Author: Jiaojiao Zhang, Dr – Shanghai Institute of Hematology, State Key Laboratory of Medical Genomics, National Research Center for Translational Medicine at Shanghai, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

  Co-Author: Shaoyuan Wang, Dr – Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Department of Hematology, Fujian Medical University Union Hospital

  Co-Author: Zhengjin Zheng, Dr – Fujian Institute of Hematology, Fujian Provincial Key Laboratory on Hematology, Department of Hematology, Fujian Medical University Union Hospital

  Co-Author: Bingzong Li, Dr – Department of Hematology, The Second Affiliated Hospital of Soochow University

  Co-Author: Han Zhang, Dr – Department of Hematology, The Second Affiliated Hospital of Soochow University

  Co-Author: Wei Xu, MD, PhD – Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital

  Co-Author: Lugui Qiu, MD – Institute of Hematology and Blood Diseases Hospital, Chinese Academy of Medical Sciences

  Co-Author: Jianyong Li, MD, PhD – Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Jiangsu Province Hospital
• 3:10 PM – 3:25 PM EDT

  Panel Discussion With Interactivity and Audience Q&A